FRPT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Freshpet Inc (FRPT) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has shown strong financial performance, positive analyst sentiment, and hedge fund buying activity, which support its growth potential. While the RSI indicates the stock is overbought in the short term, the long-term outlook remains favorable, especially with margin expansion opportunities and sustainable sales growth.
The technical indicators show a bullish trend. The MACD is positive and expanding, the RSI indicates an overbought condition at 81.99, and moving averages are aligned in a bullish pattern (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 80.903), with further upside potential to R2: 84.761.
["Hedge funds have increased their buying activity by 830.08% in the last quarter.", "Analysts have raised price targets significantly, with most maintaining Buy or Overweight ratings.", "Q4 financials showed strong growth: Revenue up 8.57% YoY, Net Income up 86.60% YoY, and EPS up 66.67% YoY.", "Gross margin improved to 43.54%, indicating better profitability.", "Freshpet's manufacturing moat and competitive advantage are highlighted by analysts as key strengths."]
["RSI indicates the stock is overbought, suggesting potential short-term price consolidation.", "Slowing growth in the broader pet food category and increased competition are concerns noted by analysts."]
Freshpet reported strong Q4 2025 financials with revenue of $285.2 million, up 8.57% YoY. Net income increased by 86.60% YoY to $33.8 million, and EPS rose by 66.67% YoY to $0.60. Gross margin improved to 43.54%, reflecting better operational efficiency. The company expects 7%-10% sales growth for 2026 and adjusted EBITDA between $205 million and $215 million.
Analysts are broadly positive on Freshpet, with multiple firms raising price targets to $90 or higher. DA Davidson, Wells Fargo, Stifel, Baird, and Morgan Stanley maintain Buy or Overweight ratings, citing strong Q4 results, margin expansion potential, and sustainable sales growth. However, TD Cowen remains cautious with a Hold rating and a lower price target of $60, citing conservative guidance and slowing growth in the pet food category.
